Last $24.70 USD
Change Today +0.03 / 0.12%
Volume 125.4K
VASC On Other Exchanges
As of 8:10 PM 09/30/14 All times are local (Market data is delayed by at least 15 minutes).

vascular solutions inc (VASC) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/4/14 - $28.21
52 Week Low
10/9/13 - $16.02
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

vascular solutions inc (VASC) Related Businessweek News

No Related Businessweek News Found

vascular solutions inc (VASC) Details

Vascular Solutions, Inc., a medical device company, provides various solutions to interventional cardiologists, interventional radiologists, electro physiologists, and vein practices worldwide. The company’s catheter products include GuideLiner catheters for deep-seating, back-out support, and optimal stenting in various interventions; Pronto extraction catheters for treating acute myocardial infarction; Micro-Introducers for performing arterial and venous catheterization procedures; Langston to measure intravascular pressure gradients for the diagnosis of aortic valve stenosis; and SmartNeedle, a doppler-guided needle device designed to provide auditory ultrasound-guided access to arteries and veins. It also offers Venture, a deflectable tip catheter used for steering guidewires in various interventions; Guardian, a hemostat valve used in catheterization procedures; SuperCross, a microcatheter for support and delivery of guidewires during coronary and peripheral catheterization procedures; Snares to retrieve or manipulate objects in the cardiovascular system; and Minnie, a support catheter used to facilitate placement and exchange of guidewires and other interventional devices. In addition, the company provides hemostat products comprising D-Stat Dry Thrombix, a thrombin-based hemostat bandage used to control bleeding at the site of femoral artery punctures; D-Stat Flowable, a flowable mixture to control bleeding in the pectoral pockets; Vasc Band radial hemostat, a compression device used to assist with bleeding control; D-Stat Radial, a wrist band to control bleeding at the radial artery access site; and accumed wrist positioning splint. Further, it offers vein products and services, such as Vari-Lase endovenous laser, a laser console and procedure kit used for the treatment of varicose veins, as well as a reprocessing service for the ClosureFAST radiofrequency vein ablation catheter. The company was founded in 1996 and is headquartered in Minneapolis, Minnesota.

406 Employees
Last Reported Date: 02/4/14
Founded in 1996

vascular solutions inc (VASC) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: $500.0K
Chief Financial Officer, Senior Vice Presiden...
Total Annual Compensation: $265.0K
Senior Vice President of Operations
Total Annual Compensation: $340.0K
Senior Vice President of Worldwide Sales
Total Annual Compensation: $280.0K
Vice President of Marketing
Total Annual Compensation: $250.0K
Compensation as of Fiscal Year 2013.

vascular solutions inc (VASC) Key Developments

Vascular Solutions Announces Settlement of Patent Lawsuit with Boston Scientific Corporation

Vascular Solutions Inc. announced that it has reached a settlement of its patent lawsuit with Boston Scientific Corporation relating to patents in the area of coronary guide extension catheters. Vascular Solutions filed the original lawsuit in U.S. District Court for the District of Minnesota in May 2013, alleging that Boston Scientific infringed three patents owned by Vascular Solutions related to rapid exchange guide extension technology by manufacturing and selling its Guidezilla guide extension catheter. Boston Scientific filed a counterclaim in July 2013, alleging that Vascular Solutions infringed a patent owned by Boston Scientific related to rapid exchange guide extension technology by manufacturing and selling its GuideLiner guide extension catheter. As part of the settlement agreement, all litigation between the two parties related to guide extension will be dismissed.

Vascular Solutions Inc. Presents at 3rd Annual InvestMNt Conference, Aug-06-2014 07:30 AM

Vascular Solutions Inc. Presents at 3rd Annual InvestMNt Conference, Aug-06-2014 07:30 AM. Venue: University of St. Thomas Corporate Room Block, 1101 LaSalle Avenue, Minneapolis, MN 55403, United States.

Vascular Solutions Comments on Justice Department Press Release Concerning Qui Tam Lawsuit Settlement Agreement

In response to a press release issued July 28, 2014 by the Department of Justice concerning the settlement of a qui tam lawsuit, Vascular Solutions Inc. issued the following comment: An agreement to settle this lawsuit was previously reached on January 22, 2014 and previously disclosed in the company's public filings, with the only event occurring being the long-delayed signing of the formal settlement agreement. The terms of the settlement are that the company will make a payment of $520,000, the company will make no admission of fault or liability, and the U.S. Attorneys' Office will dismiss the civil lawsuit with prejudice and release all civil claims brought against the company in the civil lawsuit. The press release issued July 28, 2014 by the Department of Justice contains numerous allegations which the company continues to deny.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VASC:US $24.70 USD +0.03

VASC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AtriCure Inc $14.72 USD +0.06
Cardiovascular Systems Inc $23.63 USD -1.51
CryoLife Inc $9.87 USD -0.33
Endologix Inc $10.60 USD -0.26
LeMaitre Vascular Inc $6.88 USD +0.169
View Industry Companies

Industry Analysis


Industry Average

Valuation VASC Industry Range
Price/Earnings 35.2x
Price/Sales 3.6x
Price/Book 4.1x
Price/Cash Flow 30.6x
TEV/Sales 3.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VASCULAR SOLUTIONS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at